Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.Baxter International Inc develops, manufactures and markets products for the treatment of haemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The company applies a combination of expertise in medical devices, pharmaceuticals and biotechnology and operates in three segments:Medication Delivery ' manufactures intravenous (IV) solutions and administration sets, pre-mixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anaesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies.Renal ' provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures solutions and other products for peritoneal dialysis (PD), a home-based therapy, and also distributes products for haemodialysis (HD), which is generally conducted in a hospital or clinic. This business segment was expanded in September 2009 with the acquisition of certain assets relating to Edwards Lifesciences' continuous renal replacement therapy (CRRT) product line.BioScience ' processes recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. In March 2010, Baxter acquired ApaTech, which provided Baxter with immediate entry into the emerging bone fusion field.This profile primarily concentrates on Baxter's medical device activities.Baxter has approximately 49,700 employees and conducts business in over 100 countries. In 2009, the company reported revenues of US$12.56 billion, of which approximately 58% were generated outside of the US. Baxter maintains manufacturing and distribution facilities in a number of locations in the US, Europe, Canada, Asia-Pacific and Latin America.This company report providesOverview Key contact information Introduction to the company and its current activities Summary of its financial performance Who are the company's major competitors' Key recent events in an 'at a glance' formatFinancial Review Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available) Table providing in-depth five-year financial analysis Employee data, including breakdown by company division and geographic locationStrategic FocusInvestigates the company's aims and its areas of focusProductsCore product areas, key brands, product approvals and launches Research and Development How much has been invested in R&D' Where is the research based' What alliances and agreements does the company have and with whom' Manufacturing and Distribution Identifying the company's manufacturing locations Sales and marketing facilitiesAgreements With whom has the company reached agreements and what do they involve' Key contracts awardedMergers, Acquisitions, Minority Investments and DivestmentsLitigationKey Corporate Events BioScience ' manufactures recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Baxter International Medical Device Company Intelligence Report
Published on November 2010
Report Summary
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate
activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included
on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and
a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
Baxter International Inc develops, manufactures and markets products for the treatment of haemophilia, immune disorders, infectious
diseases, kidney disease, trauma and other chronic and acute medical conditions. The company applies a combination of expertise in
medical devices, pharmaceuticals and biotechnology and operates in three segments:
Medication Delivery ' manufactures intravenous (IV) solutions and administration sets, pre-mixed drugs and drug-reconstitution
systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anaesthetics, as well as
products and services related to pharmacy compounding, drug formulation and packaging technologies.
Renal ' provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures solutions and
other products for peritoneal dialysis (PD), a home-based therapy, and also distributes products for haemodialysis (HD), which is
generally conducted in a hospital or clinic. This business segment was expanded in September 2009 with the acquisition of certain
assets relating to Edwards Lifesciences' continuous renal replacement therapy (CRRT) product line.
BioScience ' processes recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based
therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related
conditions; products for regenerative medicine, such as biosurgery products; and vaccines. In March 2010, Baxter acquired ApaTech,
which provided Baxter with immediate entry into the emerging bone fusion field.
This profile primarily concentrates on Baxter's medical device activities.
Baxter has approximately 49,700 employees and conducts business in over 100 countries. In 2009, the company reported revenues
of US$12.56 billion, of which approximately 58% were generated outside of the US. Baxter maintains manufacturing and distribution
facilities in a number of locations in the US, Europe, Canada, Asia-Pacific and Latin America.
This company report provides
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company's major competitors'
Key recent events in an 'at a glance' format
Baxter International Medical Device Company Intelligence Report Page 1/7

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company's aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D'
Where is the research based'
What alliances and agreements does the company have and with whom'
Manufacturing and Distribution
Identifying the company's manufacturing locations
Sales and marketing facilities
Agreements
With whom has the company reached agreements and what do they involve'
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
BioScience ' manufactures recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based
therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related
conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and
vaccines.
Prior to the divestiture of the Transfusion Therapies (TT) business in February 2007, the BioScience segment also manufactured
manual and automated blood and blood-component separation and collection systems.
This profile mainly concentrates on Baxter's medical device activities.
Baxter has approximately 48,500 employees and conducts business in over 100 countries. The company generates approximately
60% of its revenues outside of the US, and maintains manufacturing and distribution facilities in a number of locations in the US,
Europe, Canada, Asia, Latin America and Australia.
Table of Content
Contents
OVERVIEW ... ..1
Baxter International Medical Device Company Intelligence Report Page 2/7

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
FINANCIAL REVIEW ..2
First Half 2010 Financial Results ... 2
BioScience Division ...3
Medication Delivery Division .....4
Colleague Infusion Pump Recall .4
Renal Division .....5
2009 Financial Results .. 6
BioScience Division ...9
Medication Delivery Division ...10
Renal Division ....11
Five-Year Financial Data ... 12
Outlook . 12
Employees .. 13
STRATEGIC FOCUS .14
PRODUCTS ..15
Medication Delivery 15
Renal .18
PD Solutions ...19
Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) Products19. 19
HD Products ...19
CRRT .....19
BioScience ....20
Regenerative Medicine . 20
BioSurgery 20
RESEARCH AND DEVELOPMENT .. 22
Trials and Studies .....25
Research Agreements ...26
Kuros Biosurgery ..... 26
KUR-111 ....26
KUR-112 ....27
KUR-113 ....27
MANUFACTURING AND DISTRIBUTION ... 28
AGREEMENTS .. 30
Nikkiso ....30
SIGMA International General Medical Apparatus .30
Angiotech Pharmaceuticals .....31
Innocoll Pharmaceuticals ...31
Nycomed 32
Pfizer .32
DEKA Research & Development and HHD .32
Intercytex (now Healthpoint) ..33
Spinal Restoration ...34
Vectura ...34
Gambro ...34
Zimmer ...34
Miltenyi Biotec ...35
Mayo Clinic ...35
Becton Dickinson .....35
Baxter International Table of Contents
Minntech 35
Baxter International Medical Device Company Intelligence Report Page 3/7

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Med Enclosure ...36
MERGERS AND ACQUISITIONS 37
ApaTech ..37
Assets Relating to Edwards Lifesciences' CRRT Product Line .37
Willow Healthcare Services 38
MAAS Medical ....38
Spinal Restoration ...38
Epic Therapeutics ....38
Wockhardt Life Sciences' IV Fluids Business ...38
Fusion Medical Technologies ...38
Autros Healthcare Solutions ....38
Asta Medica Onkologie 39
Nexell Therapeutics' Cell Processing Products .....39
Cook Pharmaceutical Solutions .....39
Dade Behring's Technical Service Operations 39
Sera-Tec Biologicals .39
Orion's Intravenous Infusion and Nutrition Businesses ...39
Althin Biopharm .....39
Althin Medical ...40
Sabratek's Infusion Pump Business and Rocap Product Line 40
Pharmacia & Upjohn's German Nutrition Business ....40
Bieffe Medital's IV Therapy and Irrigating Solutions Business ....40
Clintec Nutrition Business ..40
MINORITY INVESTMENTS .41
Sigma International 41
DIVESTITURES 42
Transfusion Therapies Business .....42
Disposable Airway Management Business .....42
Renal Service Businesses ...42
PFC Therapeutics .....43
Admixture Products and Services .43
Edwards Japan ...43
Cardiovascular Business ....43
Productivity Systems Business Assets .43
Sure-Med .....43
Industrial and Life Sciences Division ..43
Diagnostic Products Manufacturing Operations 44
Tower Packaging Business 44
Caremark .... 44
JOINT VENTURES ... 45
Eczacibasi Baxter Hospital Supply Products Company ....45
LITIGATION 46
Fresenius ..... 46
Peritoneal Dialysis Litigation ... 46
Haemodialysis Litigation .... 46
KEY CORPORATE EVENTS ..47
List of Tables
SUMMARY OPERATING RESULTS .. iii
Baxter International Medical Device Company Intelligence Report Page 4/7

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Recent Key Events .1
Baxter - 2010 Quarterly Financial Results 2
Baxter - 2010 Quarterly Net Sales by Business Segment and Geographic Area ..3
Baxter BioScience Division - 2010 Quarterly Net Sales by Product Sector 3
Baxter Medication Delivery Division - 2010 Quarterly Net Sales by Product Sector ...4
Baxter Renal Division - 2010 Quarterly Net Sales by Product Sector .5
Baxter - Annual Financial Results, 2005-2009 ...6
Baxter - Annual Net Sales by Business Segment and Geographic Area, 2005-2009 .7
Baxter BioScience Division - Annual Net Sales and Pre-tax Income, 2005-2009 .9
Baxter Medication Delivery Division - Annual Net Sales and Pre-tax Income, 2005-2009 ..10
Baxter Renal Division Annual Net Sales and Pre-tax Income, 2005-2009 .. 11
Baxter ' Five-Year Financial Summary . 12
(years ended 31st December, US$ million) ... 12
Baxter ' Global Location of Employees, 2007-2009 13
Baxter ' Summary of Medical Delivery Medical Device Products ...16
Baxter ' Summary of Renal Medical Device Products ..20
Baxter ' Summary of BioSurgery Products .21
Baxter - Annual R&D Expenses, 2005-2009 23
Baxter ' Medical Device R&D Pipeline ...24
Baxter's Principal Manufacturing Facilities by Segment, December 2009 ..28
Agreements Summary ...30
Mergers and Acquisitions Summary 37
List of Charts
Baxter - Annual Net Sales and Operating Income, 2005-2009 ....6
Baxter - Annual Sales by Business Sector, 2005-2009 8
Baxter - Annual Sales by Geographic Area, 2005-2009 ...8
Baxter BioScience Division Sales by Product Sector, 2005-2009 ...9
Baxter Medication Delivery Division - Annual Sales by Product Sector, 2005-2009 .10
Baxter Renal Division - Annual Sales by Product Sector, 2005-2009 11
Baxter - 2009 Sales of Medical Delivery Products .....16
Top 5 Dialysis Providers Worldwide, 2009 ....18
Baxter - 2009 Renal Product Sales ....19
Baxter - 2009 BioScience Product Sales ..21
Baxter International Medical Device Company Intelligence Report Page 5/7

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Baxter International Medical Device Company Intelligence Report
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 460.94 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Baxter International Medical Device Company Intelligence Report Page 6/7

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Baxter International Medical Device Company Intelligence Report Page 7/7